Teal Enhancements for Cross-Industry Adoption
Project Scope |
Research: Conduct a detailed analysis of the current teal framework and identify areas where flexibility can be introduced. A Proof-of-Concept will be provided after research. Development: Create new functionalities that allow for the re-formatting, post-processing, and decoration of outputs generated by existing teal modules.Testing: Develop test cases to ensure the new functionalities are compatible with existing modules and meet the customisation needs of different companies.Documentation: Update the framework's documentation to include instructions on how to use the new features.Training & Support: Provide training and ongoing support to users within the pharma industry to facilitate the adoption of the enhanced teal framework. |
Problem Statement |
---|
The teal framework has provided significant value to the pharma community via its power of interactive data exploration in clinical trials and beyond, together with its pre-built modules in teal.modules.clinical, which analyse standardised clinical data and generate outputs that meet general industry standards. However, the industry's varied standards and analysis needs may pose a limitation to wider adoption of teal across different companies. Sometimes this has led to the need for companies to develop their own ad hoc clinical modules from scratch to meet their specific requirements, which can be resource-intensive and inefficient. The proposed project seeks to address this challenge by enhancing features and flexibilities of the teal framework. With these enhancements, users can tailor the output formatting and presentation without modifying the core modules, ensuring that the framework remains widely usable across different companies while reducing the overhead of custom module development. |
Problem Impact |
---|
The project aims to introduce enhanced flexibility into the teal framework. By adding new functionalities that allow users to re-format, post-process, and decorate outputs generated by any teal module, the project will enable the pharmaceutical industry to standardise outputs according to individual company requirements without the need to develop custom modules from scratch. This will also empower the reusability and scalability of existing modules across different companies. Key Benefits:
|
Project Leads | |
---|---|
Peyman Eshghi, Johnson & Johnson | |
Nina Qi, Gene | |
Nicholas Masel, Johnson & Johnson | nmasel@its.jnj.com |
Alex Pearce, PHUSE Project Assistant |
CURRENT STATUS Q4 2024 |
|
Objectives & Deliverables | Timelines |
---|---|
Project Initiation and requirements gathering | Q4 2024 |
Development of flexibility features | Q2 2025 |
Initial testing and debugging | Q3 2025 |
User acceptance testing and final adjustments | Q4 2025 |
Documentation, training and deployment | Q1 2025 |
Interested in joining? |
---|
If you are interested in joining this project, please email workinggroups@phuse.global |